The Cannigma
MAY 17, 2022
We also don’t know which, if any, terpenes have an effect on creativity. The best strains for creativity are Type II, with a balance of THC and CBD and a terpene profile that includes pinene, linalool, and beta-caryophyllene. Best terpenes for creativity. So if cannabis does improve creativity for some people, how?
The Cannigma
AUGUST 14, 2022
There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. The best weed strains to help you focus have a balance of CBD and THC, are energizing and stress-relieving, and have a terpene profile that includes pinene, linalool, or beta-caryophyllene.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
DECEMBER 12, 2022
Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine. A typical dose is 150-500 mcg.
Green Relief
MAY 13, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.
Green Relief
MAY 12, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2002, the Journal of Neuroscience reported that the impact of induced cerebral ischemia is much more severe in CB1 knockout mice than in “wild type” mice with cannabinoid receptors.
Cannabis Law Report
NOVEMBER 24, 2021
Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Bonini et al.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Fig 1: Sucralose (In Study).
Expert insights. Personalized for you.
128 
Let's personalize your content